Levi Garraway

Levi A. Garraway is the founder of Tango Therapeutics Sub, Inc. (2017) and Foundation Medicine, Inc. (2009).
Current jobs include Director, Chief Medical Officer & Executive VP at Genentech, Inc. (since 2019), Director at The Damon Runyon Cancer Research Foundation (since 2021), Chief Medical Officer & Head-Product Development at Roche Holding AG (since 2023), Trustee at Dana-Farber Cancer Institute, Inc. (since 2023), Member at American Society of Clinical Oncology, Inc. (since 2012), Member at American Association for the Advancement of Science (since 2010), Member at National Academy of Medicine (United States) (since 2020), Member at Association of American Physicians (since 2015), Member at American Association for Cancer Research (since 2007), and Member at American Society for Clinical Investigation (current).
Former jobs include Director at American Association for Cancer Research, Senior VP-Global Development & Medical Affairs at Eli Lilly & Co. (2017-2019), Associate Professor at Dana-Farber Cancer Institute, Inc. (2011-2016), Member at The National Medical Association (2000-2003), Member at American Society for Biochemistry & Molecular Biology, Inc. (2011-2013), Institute Member at The Broad Institute, Inc. (2014-2016), and Associate Professor at Harvard Medical School (2011-2016).
Education includes an undergraduate degree from Harvard Medical School (1990) and a doctorate from Harvard Medical School (1999).